Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Yiqun Jin"'
Autor:
Xuesong Bai, Jianhao Huang, Yiqun Jin, Jiemin Chen, Shengnan Zhou, Liangbo Dong, Xianlin Han, Xiaodong He
Publikováno v:
Cell Death Discovery, Vol 10, Iss 1, Pp 1-11 (2024)
Abstract Biliary tract cancers (BTCs) are relatively rare malignancies with a poor prognosis. For advanced BTCs, the efficacy of current chemotherapeutic approaches is limited. Consequently, there is an urgent need to deepen our understanding of the
Externí odkaz:
https://doaj.org/article/e46c5e1968ae495f81c08f04523d2d8f
Autor:
Jun Ye, Renjie Li, Yanfang Yang, Wujun Dong, Yujie Wang, Hongliang Wang, Tong Sun, Lin Li, Qiqi Shen, Caiyun Qin, Xiaoyan Xu, Hengfeng Liao, Yiqun Jin, Xuejun Xia, Yuling Liu
Publikováno v:
Journal of Nanobiotechnology, Vol 19, Iss 1, Pp 1-18 (2021)
Abstract Background Standard chemotherapy with taxanes, such as paclitaxel (PTX), remains the mainstay of systemic treatment of triple-negative breast cancer. Nanotechnology-based formulations have gradually replaced PTX injection and are widely used
Externí odkaz:
https://doaj.org/article/1aae874d2f2746c7ad87c565406733c3
Autor:
Bai. Xue-song, Yiqun Jin
PurposePyroptosis is an inflammatory form of cell death associated with tumorigenesis and progression. However, the prognostic value of pyroptosis-related genes (PRGs) in hepatocellular carcinoma (HCC) have not been elucidated.MethodsWe downloaded mR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a51a691dd2b3e4017e84153af92a19f
https://doi.org/10.21203/rs.3.rs-1020197/v1
https://doi.org/10.21203/rs.3.rs-1020197/v1
Autor:
Yuling Liu, Jing Jin, Yingying Meng, Yanfang Yang, Ming Ji, Yiqun Jin, Xuejun Xia, Lin Li, Xiaoguang Chen, Wujun Dong, Jun Ye, Yue Gao, Hongliang Wang
Publikováno v:
International Journal of Nanomedicine. 14:3203-3220
Background: Tumor-associated macrophages (TAMs) are critical in tumor progression and metastasis. Selective targeting of TAMs holds great potential to ameliorate the immunosuppressive tumor microenvironment and enhance the efficacy of antitumor thera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f59a6280d6510de9b0c088759808731
https://doi.org/10.2147/ijn.s207589
https://doi.org/10.2147/ijn.s207589
Autor:
Jun Ye, Wujun Dong, Hengfeng Liao, Xue Han, Yuling Liu, Huazhen Hao, Yanfang Yang, Yiqun Jin, Bangyuan Wang, Xuejun Xia
Publikováno v:
Pharmaceutical Research. 34:1244-1254
To overcome the drawbacks of high dose regimen and improve the outcomes of chemotherapy at a low dose, an immunotherapeutic nanoemulsion based combination of chemotherapeutic agent (paclitaxel) with immunomodulatory agent (vitamin E) was developed an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae5bc18d1b6d2791756aedc00b47abd9
https://doi.org/10.1007/s11095-017-2141-3
https://doi.org/10.1007/s11095-017-2141-3
Publikováno v:
International Journal of Pharmaceutics. 513:8-16
Multidrug resistance (MDR) is a major obstacle for clinical application of paclitaxel (PTX). Recent studies have suggested that baicalein (BA) might be a potent MDR reversal agent with the ability of P-glycoprotein inhibition and oxidative stress aug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2ab65ec6cdde1d8a0d35b555f8e71f1
https://doi.org/10.1016/j.ijpharm.2016.09.001
https://doi.org/10.1016/j.ijpharm.2016.09.001
Publikováno v:
Journal of Controlled Release. 259:e72
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b24ebe4764373cce489bf19edd77315
https://doi.org/10.1016/j.jconrel.2017.03.162
https://doi.org/10.1016/j.jconrel.2017.03.162